Skip to main content
. Author manuscript; available in PMC: 2015 Sep 21.
Published in final edited form as: Analyst. 2014 Sep 21;139(18):4401–4410. doi: 10.1039/c4an00990h

Fig. 4.

Fig. 4

(A) Model of PEGylated ProCA1 metalated with GdIII (pink: GdIII; blue: metalation site; green: ProCA1; red and green: PEG; yellow and red: water); (B) Relaxivity values of ProCA1 and PEGylated-ProCA1 (blue at 3 T and red at 9.4 T). Reprinted from the Journal of Inorganic Biochemistry, 107, S. Li, J. Jiang, J. Zou, J. Qiao, S. Xue, L. Wei, R. Long, L. Wang, A. Castiblanco, N. White, J. Ngo, H. Mao, Z.-R. Liu and J. J. Yang, PEGylation of Protein-Based MRI Contrast Agents Improves Relaxivities and Biocompatibilities, 111–118, Copyright 2013, with permission from Elsevier.